Table 1: Characteristics of patients ( ).

Mean age50 years21–70
Mean CA 125 before
  SLL
1879 UI/mL21–31599
FIGO stageII13 (15%)
III63 (74%)
IV 9 (11%)
Histological typesSerous57 (67.1%)
Endometrial11 (12.9%)
Mucinous4 (4.7%)
Mixed4 (4.7%)
Unclassified types9 (10.6%)
GradeI 3 (3.5%)
II12 (14.1%)
III14 (16.5%)
Optimal cytoreduction after primary surgery (R 1 cm)FIGO II–IV55 (64.7%)
Type of primary chemotherapyCisplatin-cyclophosphamide68  (70%)
Carboplatin-paclitaxel17  (30%)
SLL duration120.1 min45–240 min
Hospital stay after SLL8.5 days5–26